Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/116149
Title: Benefits of a 12-week pulmonary rehabilitation programme in interstitial lung diseases : 1 year post completions
Authors: Sciriha, Anabel
Lungaro-Mifsud, Stephen
Agius, Tonio P.
Scerri, Josianne
Fsadni, Peter
Montefort, Stephen
Keywords: Lungs -- Diseases, Obstructive
Lungs -- Diseases -- Medical rehabilitation
Lungs -- Diseases, Obstructive -- Treatment
Lungs -- Diseases -- Patients -- Rehabilitation
Respiratory therapy
Chest -- Diseases -- Treatment
Issue Date: 2023
Publisher: Taylor & Francis
Citation: Sciriha, A., Lungaro-Mifsud, S., Agius, T., Scerri, J., Fsadni, P., & Montefort, S. (2023). Benefits of a 12-week pulmonary rehabilitation programme in interstitial lung diseases: 1 year post completions. European Journal of Physiotherapy, DOI: 10.1080/21679169.2023.2287511
Abstract: Objectives: Evidence on the efficacy of Pulmonary Rehabilitation in the management of ILD is growing. Despite studies reporting benefits, few studies have investigated the long-term effects in such patients, resulting in a call for such research. Therefore, this study aimed to evaluate the effectiveness of a 12-week PR programme on exercise tolerance, quality of life and physical activity, 6- and 12-months post completion. Design: An observational, prospective, quasi experimental type of study. Setting: Out-Patient Physiotherapy Department. Participants: 60 participants diagnosed with Interstitial Lung Disease. Intervention: A 12week PR programme was delivered with outcome measures assessed throughout the programme and at the 28th and 52nd week. Main Outcome Measures: 6-min walking distance test, Dyspnoea Borg Scale, St George’s Respiratory Questionnaire and Hospital Anxiety and Depression Score were measured. Results: Maintenance of effects was noted in SGRQ scores p = 0.005 on completion of the 12week programme, depression scores (p = 0.038 at week 28 and p = 0.008 at week 52) and BODE index resulting in a statistically significant improvement at the 52nd week (p = 0.017). Benefits of in the 6MWT were maintained at 28week but had a statistically significant decline at 52weeks post completion (p = 0.013). Dyspnoea scores increased post completion of the 12week PR programme at both the 28th week (p = 0.008) and 52nd week (p = 0.005). Conclusion: Improvements were maintained up to 1 year post completion in most outcome measures or else showed benefits till the 52week.
URI: https://www.um.edu.mt/library/oar/handle/123456789/116149
Appears in Collections:Scholalry Works - FacHScMH



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.